E
Rapid Dose Therapeutics Corp. DOSE
CNSX
Recommendation
Sell
Prev Close
$0.195
Volume
--
Avg Vol (90D)
43,339
Market Cap
$17.38M
Dividend & Yield
--
52-Week Range
$0.125 - $0.325
P/E (TTM)
--
EPS (TTM)
-$0.0362
My Lists My Alerts
Weiss Ratings DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Very Weak
Risk Grade E+
Reward Grade E
Rating Factors DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Very Weak
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta -0.07
Price History DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return -10.53%
30-Day Total Return -15.00%
60-Day Total Return -29.17%
90-Day Total Return -43.33%
Year to Date Total Return -24.44%
1-Year Total Return 17.24%
2-Year Total Return 88.89%
3-Year Total Return -40.35%
5-Year Total Return -40.35%
52-Week High % Change -40.00%
52-Week Low % Change 56.00%
Price DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $0.33
52-Week Low Price $0.13
52-Week Low Price (Date) Sep 12, 2024
52-Week High Price (Date) Oct 21, 2024
Valuation DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 17.38M
Enterprise Value 19.16M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.04
Earnings Per Share Growth 41.41%
Price/Earnings To Growth --
Price/Sales (TTM) 20.74
Price/Book (Q) -8.55
Enterprise Value/Revenue (TTM) 16.27
Price $0.17
Enterprise Value/EBITDA (TTM) -6.97
Enterprise Value/EBIT -6.51
Market Cap Category Nano Cap
Dividends and Shares DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 124.17M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 416 477 1052
Address 1121 Walker's Line Burlington, ON L7N 2G4
Website rapid-dose.com
Country Canada
Year Founded --
Profitability DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) -250.08%
Profit Margin -360.57%
Management Effectiveness DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -138.33%
Return on Equity --
Income Statement DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) 1.18M
Total Revenue (TTM) 1.18M
Revenue Per Share $0.01
Gross Profit (TTM) 702.40K
EBITDA (TTM) -2.75M
EBIT (TTM) -2.95M
Net Income (TTM) -4.25M
Net Income Avl. to Common (TTM) -4.25M
Total Revenue Growth (Q YOY) 112.90%
Earnings Growth (Q YOY) -38.03%
EPS Diluted (TTM) -0.04
EPS Diluted Growth (Q YOY) -14.29%
Balance Sheet DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 28.60K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 456.40K
Total Preferred Equity (Q) --
Total Equity (Q) -2.93M
Current Ratio (Q) 0.202
Book Value Per Share (Q) -$0.02
Total Assets (Q) 1.19M
Total Current Liabilities (Q) 2.26M
Total Debt (Q) 1.86M
Total Liabilities (Q) 4.12M
Total Common Equity (Q) -2.93M
Cash Flow DOSE - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) 1.71M
Net Change in Cash (TTM) -92.20K
Levered Free Cash Flow (TTM) -1.63M
Cash from Operations (TTM) -1.80M
Weiss Ratings